| For: | Chen QH, Zhang Y, Gu X, Yang PL, Yuan J, Yu LN, Chen JM. Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor. World J Stem Cells 2024; 16(8): 811-823 [PMID: 39219725 DOI: 10.4252/wjsc.v16.i8.811] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v16/i8/811.htm |
| Number | Citing Articles |
| 1 |
Samuel C. F. Couto, Miquéias Lopes-Pacheco, Vanderson Rocha, Claudia C. Dos Santos, Patricia R. M. Rocco. Extracellular vesicles from mesenchymal stromal cells as a promising therapy for ARDS: a systematic review of preclinical studies. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1665948
|
| 2 |
Junchao Sun, Yujie Zhao, Zhoujiang Qu, Shudong Sun, Kun Wang. Cell-free adipose extract inhibits hypertrophic scar formation through collagen remodeling and antiangiogenesis. Open Medicine 2025; 20(1) doi: 10.1515/med-2025-1249
|
| 3 |
Zhao Zhang, Xin-Yun Shan, Ce Liang, Lan Zhao, Xiao-Qian Shan. Microvesicles derived from mesenchymal stem cells: A promising therapeutic strategy for acute respiratory distress syndrome-related pulmonary fibrosis?. World Journal of Stem Cells 2025; 17(1): 101036 doi: 10.4252/wjsc.v17.i1.101036
|
| 4 |
Kyong-Su Park, Cecilia Lässer, Jan Lötvall. Extracellular vesicles and the lung: from disease pathogenesis to biomarkers and treatments. Physiological Reviews 2025; 105(3): 1733 doi: 10.1152/physrev.00032.2024
|
